Biotech, HIV, Life Sciences
PATH Gets $52M for HIV Work
Luke Timmerman 4/24/09
PATH, the nonprofit organization that works to reduce health disparities worldwide, has nailed down a pair of grants worth $52 million to prevent HIV and improve how communities respond to the epidemic. One grant for $35 million over three years from the U.S. Agency for International Development, to strengthen the public health response to HIV in Ethiopia. The other is a three-year, $17 million grant from the Canadian International Development Agency to strengthen HIV prevention efforts.
Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.
